Skip to Content
MilliporeSigma
All Photos(1)

Documents

1445357

USP

Modafinil Related Compound B

United States Pharmacopeia (USP) Reference Standard

Synonym(s):

2-[(Diphenylmethyl)sulfonyl]acetamide, 2-(Benzhydrylsulfonyl)acetamide, Modafinil sulfone

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C15H15NO3S
CAS Number:
118779-53-6
Molecular Weight:
289.35
Beilstein/REAXYS Number:
9199801
MDL number:
MFCD00877512
UNSPSC Code:
41116107
PubChem Substance ID:
329750481
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

modafinil

manufacturer/tradename

USP

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

NC(=O)CS(=O)(=O)C(c1ccccc1)c2ccccc2

InChI

1S/C15H15NO3S/c16-14(17)11-20(18,19)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

InChI key

ZESNOWZYHYRSRY-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Modafinil Related Compound B USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

High-performance liquid chromatographic determination of modafinil and its two metabolites in human plasma using solid-phase extraction.
Burnat, Pascal, Fabrice Robles, and Bernard Do.
Journal of Chromatography. B, Biomedical Sciences and Applications, 706.2, 295-304 (1998)
Mona Darwish et al.
Clinical therapeutics, 37(2), 325-337 (2014-12-03)
Polypharmacy is common in psychiatry practice and can lead to an increased risk of drug interactions. Armodafinil, a wakefulness-promoting agent, has been studied as adjunctive therapy for the treatment of major depressive episodes associated with bipolar I disorder. Armodafinil and

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service